Stocksigma LogoStocksigma Logo

Aspira Pathlab & Diagnostics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

■ Revenue: 626 (-22.6% YoY | +1.5% QoQ) ■ EBITDA: -67.5 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -10.8 (Profit to Loss YoY | Profit

Aspira Pathlab & Diagnostics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

Aspira Pathlab & Diagnostics Ltd · Outcome · 06 Nov 2026, 9:52 pm

Aspira Pathlab & Diagnostics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 626 (-22.6% YoY | +1.5% QoQ) ■ EBITDA: -67.5 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -10.8 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: -116 (Profit to Loss YoY | -2975.6% QoQ) ■ EPS (INR): -1.13 (Profit to Loss YoY | -2725.0% QoQ)

Original exchange filing (PDF)

More announcements from Aspira Pathlab & Diagnostics Ltd

All Aspira Pathlab & Diagnostics Ltd announcements